These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20462599)

  • 1. The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue.
    Jung H; Jun KH; Jung JH; Chin HM; Park WB
    J Surg Res; 2011 May; 167(2):e185-91. PubMed ID: 20462599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
    Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF
    Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
    Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
    Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
    Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
    J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions.
    Cunningham SC; Kamangar F; Kim MP; Hammoud S; Haque R; Iacobuzio-Donahue CA; Maitra A; Ashfaq R; Hustinx S; Heitmiller RE; Choti MA; Lillemoe KD; Cameron JL; Yeo CJ; Schulick RD; Montgomery E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):281-7. PubMed ID: 16492916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
    Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
    Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of intestinal claudins in high-risk synchronous and metachronous multiple gastric epithelial neoplasias after initial endoscopic submucosal dissection.
    Semba S; Hasuo T; Satake S; Nakayama F; Yokozaki H
    Pathol Int; 2008 Jun; 58(6):371-7. PubMed ID: 18477216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma.
    Turunen M; Talvensaari-Mattila A; Soini Y; Santala M
    Anticancer Res; 2009 Dec; 29(12):5185-9. PubMed ID: 20044634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of N-cadherin expression in gastric cancer.
    Kamikihara T; Ishigami S; Arigami T; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Ueno S; Natsugoe S
    Pathol Int; 2012 Mar; 62(3):161-6. PubMed ID: 22360503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic values of Id-1 and Id-3 in gastric adenocarcinoma.
    Yang HY; Liu HL; Liu GY; Zhu H; Meng QW; Qu LD; Liu LX; Jiang HC
    J Surg Res; 2011 May; 167(2):258-66. PubMed ID: 20080245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of claudins and prognostic factors in some gastrointestinal diseases].
    Gyorffy H
    Magy Onkol; 2009 Dec; 53(4):377-83. PubMed ID: 20071310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of claudin-4 between intestinal and diffuse-type gastric cancer.
    Kuo WL; Lee LY; Wu CM; Wang CC; Yu JS; Liang Y; Lo CH; Huang KH; Hwang TL
    Oncol Rep; 2006 Oct; 16(4):729-34. PubMed ID: 16969486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
    Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
    Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma.
    Väre P; Loikkanen I; Hirvikoski P; Vaarala MH; Soini Y
    Oncol Rep; 2008 Jan; 19(1):25-31. PubMed ID: 18097572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis.
    Matsuda M; Sentani K; Noguchi T; Hinoi T; Okajima M; Matsusaki K; Sakamoto N; Anami K; Naito Y; Oue N; Yasui W
    Pathol Int; 2010 Oct; 60(10):673-80. PubMed ID: 20846265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
    Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
    Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival.
    Ohtani S; Terashima M; Satoh J; Soeta N; Saze Z; Kashimura S; Ohsuka F; Hoshino Y; Kogure M; Gotoh M
    Gastric Cancer; 2009; 12(1):43-51. PubMed ID: 19390931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.